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Pathogens in the genus Campylobacter are the most common cause of food-borne
bacterial gastro-enteritis. Campylobacteriosis, caused principally by Campylobacter
jejuni and Campylobacter coli, is transmitted to humans by food of animal origin,
especially poultry. As for many pathogens, antimicrobial resistance in Campylobacter
is increasing at an alarming rate. Erythromycin prescription is the treatment of choice
for clinical cases requiring antimicrobial therapy but this is compromised by mobility of
the erythromycin resistance gene erm(B) between strains. Here, we evaluate resistance
to six antimicrobials in 170 Campylobacter isolates (133 C. coli and 37 C. jejuni)
from turkeys. Erythromycin resistant isolates (n = 85; 81 C. coli and 4 C. jejuni) were
screened for the presence of the erm(B) gene, that has not previously been identified
in isolates from turkeys. The genomes of two positive C. coli isolates were sequenced
and in both isolates the erm(B) gene clustered with resistance determinants against
aminoglycosides plus tetracycline, including aad9, aadE, aph(2′′)-IIIa, aph(3′)-IIIa, and
tet(O) genes. Comparative genomic analysis identified identical erm(B) sequences
among Campylobacter from turkeys, Streptococcus suis from pigs and Enterococcus
faecium and Clostridium difficile from humans. This is consistent with multiple horizontal
transfer events among different bacterial species colonizing turkeys. This example
highlights the potential for dissemination of antimicrobial resistance across bacterial
species boundaries which may compromise their effectiveness in antimicrobial therapy.
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INTRODUCTION
The World Health Organization (WHO) has recently published
a list of bacteria for which new antibiotic therapies are urgently
needed, with Campylobacter classified as high priority (WHO,
2017). This is of concern as campylobacteriosis is the most
commonly notified bacterial foodborne infection in the European
Union (European Food Safety Authority [EFSA]/European
Centre for Disease Prevention and Control [ECDC], 2016a).
The disease is principally caused by Campylobacter jejuni and
Campylobacter coli following the ingestion of contaminated food
and drink, with consumption of poultry meat recognized as
a major risk factor (Wilson et al., 2008; Whiley et al., 2013).
Infection can be associated with extra intestinal pathologies and
sequelae such as reactive arthritis or Guillain-Barré syndrome
(Nachamkin et al., 1998), but it is usually self-limiting. Treatment
of severe infection occasionally requires antimicrobial therapy,
often with erythromycin (European Food Safety Authority
[EFSA]/European Centre for Disease Prevention and Control
[ECDC], 2016b) and to a lesser extent with gentamicin, the later
used occasionally when infection becomes systemic (Lehtopolku
et al., 2009). Although fluoroquinolones were commonly used
in the past, the rising of resistance among Campylobacter
isolates makes these antibiotics ineffective (Kassem et al.,
2016).
Erythromycin inhibits protein synthesis by binding to the
ribosome and blocking the exit of the nascent peptide chain
(Fyfe et al., 2016). Erythromycin resistance in bacterial isolates
from animals and humans is associated with the presence
of erm genes (Weisblum, 1995). The most widely distributed
erm gene class is erm(B), which encodes an rRNA methylase
which produces cross-resistance to macrolides, lincosamides
and streptogramins B (MLSB phenotype) (Leclercq, 2002).
The erm(B) encoded enzyme acts on the 23S rRNA gene
by methylating an adenine residue that hinders antibiotic
binding-to the ribosome (Weisblum, 1995). The erm(B) gene
is present in a variety of Gram-positive bacteria, including
enterococci, streptococci, and staphylococci (Jensen et al., 1999).
The potential for interspecies horizontal gene transfer (HGT)
(Conwell et al., 2017) has facilitated the emergence of resistance
in multiple species including Gram-negative bacteria of the
genera Bacteroides, Shigella, Escherichia, Klebsiella, and recently
Campylobacter (Shoemaker et al., 2001; Soge et al., 2006; Phuc
Nguyen et al., 2009; Qin et al., 2014). Resistance in Campylobacter
has been associated with ribosomal mutations, efflux pumps and
the erm(B) gene that has been identified in isolates from China
and Spain (Qin et al., 2014; Florez-Cuadrado et al., 2016; Fyfe
et al., 2016). Recent work has reported high-level erythromycin
resistance (MIC≥ 1024 mg/L) in a C. coli isolate carrying erm(B)-
in a genomic island along with other determinants conferring
resistance to aminoglycosides, tetracycline and streptothricin
(Florez-Cuadrado et al., 2016). Thus, eight types of erm(B)-
carrying genomic islands have been differentiated (Qin et al.,
2014; Wang et al., 2014; Florez-Cuadrado et al., 2016), all of
which share aminoglycoside resistance genes in addition to
other determinants, likely leading to co-selection after genetic
mobilization (Chapman, 2003).
Improved understanding of the distribution of resistance
genes within bacterial species in different host niches, and
the mobility of these genes between populations, could be
important for identifying source and sink populations. In the
case of Campylobacter, the erm(B) gene has been identified in
C. coli isolates from chicken, ducks, swine, and humans and
from C. jejuni isolated from chicken (Qin et al., 2014; Wang
et al., 2014; Deng et al., 2015) but other host species may
be relevant. Turkeys are among the top 10 farmed animals in
Europe and the United States with an estimated 323 million
birds reared anually (FAOSTAT, 2017). While studies have
shown that turkeys are an important host species harboring
large numbers of C. jejuni and C. coli, the resistance status
of these strains is not well-characterized. This has lead to the
inclusion of this animal species in international surveillance
programs to evaluate the levels of antibiotic resistance. In this
study we carried out combined molecular microbiology and
whole genome sequencing approaches to evaluate the presence
of erm(B) and it’s genetic background in Campylobacter isolates
obtained from turkeys sampled in Spain. The comparison with
erm(B) sequences from other host species might allow further
description of the microevolutionary events associated with the
acquisition of this antibiotic resistance genes in Campylobacter.
MATERIALS AND METHODS
Strains and Growth Conditions
Campylobacter isolates were recovered in 2014 (n = 170;
133 C. coli and 37 C. jejuni) from turkey samples obtained
in the framework of the European Antimicrobial Resistance
Surveillance program (DC 652/2013) in Spain (European
Comission, 2013). Samples were collected at the largest turkey
slaughterhouses in Spain located in different regions within the
country. Each Campylobacter isolate represented a single farm
and they were obtained by culturing pooled feces from turkeys
(117 pooled samples: 10 animals per pool, 1170 individual
fecal samples analyzed). Each pooled sample was cultured on
Campylobacter blood-free selective medium (CCDA) (Oxoid).
Inoculated media were incubated at 42◦C for 48 h under
microaerobic conditions with a commercial gas-generating
system (atmosphere generator system, Oxoid). Suspected
colonies were subcultured onto blood agar (BioMérieux) at 37◦C
for 48 h. All strains were identified by conventional multiplex
PCR of the genus Campylobacter that allows the differentiation
between C. coli and C. jejuni with specific primers, as described
previously (Ugarte-Ruiz et al., 2012).
Antimicrobial Susceptibility Testing
Broth microdilution methods were performed to determine
the antimicrobial susceptibility of the Campylobacter isolates
[minimum inhibitory concentrations (MICs)]. The following
antimicrobials were tested: tetracycline, ciprofloxacin, nalidixic
acid, erythromycin, streptomycin, and gentamicin. Isolates were
grown on blood agar plates (bioMérieux) and incubated for
48 h at 37◦C under microaerophilic conditions. Growth from
these cultures was suspended in sterilized water and adjusted
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at 0.5 McFarland. Fifty microliters of these inocula were added
to 11 mL of cation-adjusted Mueller-Hinton broth (TREK
Diagnostics Systems), and supplemented with 600 µL of lysed
horse blood prepared in house from defibrinated horse blood
(Oxoid). EUCAMP2 microdilution plates (TREK Diagnostics
Systems) were inoculated and incubated under microaerophilic
conditions at 37◦C for 48 h. C. jejuni strain ATCC 33560 was used
as a control for antimicrobial susceptibility test. Following the
commission decision 2013/652/UE, the epidemiological cut-offs
values considered were those described by EUCAST (EUCAST,
2017). Campylobacter isolates resistant to erythromycin (MICs:
>8 mg/L to C. coli and >4 mg/L to C. jejuni) were selected to
evaluate the presence of erm(B) gene.
Identification of erm(B) Gene and
Whole-Genome Sequencing
The RNA methylase gene erm(B) was identified by PCR as
described previously (Chen et al., 2007). Amplicons were
detected by gel electrophoresis using 2% agarose gels containing
10 mg/ml SYBR Safe DNA gel stain (Invitrogen) for 40 min
at 100 mA. DNA fractions were sequenced and compared
using Sanger sequencing and MEGA software (version 5.05)
respectively (Tamura et al., 2011; Heather and Chain, 2016).
erm(B)-positive Campylobacter isolates were selected for whole
genome sequencing. For DNA extraction, Campylobacter isolates
were grown on blood agar plates (48 h at 42◦C under
microaerophilic conditions) and DNA was extracted using
a QiAmp DNA mini kit (Qiagen). DNA was quantified
using a Nanodrop spectrophotometer before sequencing. High-
throughput genome sequencing was performed using a benchtop
MiSeq sequencer (Illumina), and the short read paired-end data
was assembled using the de novo assembly algorithm, SPAdes
(Bankevich et al., 2012). Genome sequences were archived in
the web-accessible Bacterial Isolate Genome Sequence Database:
BIGSdb (Jolley and Maiden, 2010), which included functionality
for identifying MLST profiles based on the pubMLST database1.
Allelic diversity was evaluated using a gene-by-gene approach for
genome alignment and comparison with the BLAST algorithm as
previously described (Sheppard et al., 2012).
RESULTS
Antimicrobial Susceptibility Testing
A total of 170 Campylobacter isolates (133 C. coli and 37
C. jejuni) were tested for susceptibility to six antimicrobials.
Antimicrobial resistance profiles (Table 1) and MIC distributions
were recorded (Supplementary Table S1). The highest proportion
of antimicrobial resistance was to tetracycline (168/170; 98.8%)
followed by nalidixic acid/ciprofloxacin (164/170; 96.4%),
erythromycin (85/170; 50%), streptomycin (82/170; 48.2%), and
finally gentamicin (13/170; 7.6%). Considering C. coli and
C. jejuni separately, higher prevalence of resistance was observed
in C. coli for erythromycin, streptomycin, and gentamicin
(Fisher’s exact test: p < 0.001). Based upon The European
1https://pubmlst.org/campylobacter; accessed May 9, 2017
Food Safety Authority (EFSA) criteria for quantifying multi-
drug resistance (MDR; resistance to at least three classes
of antimicrobials tested), seven MDR profiles were recorded
for Campylobacter isolates (Table 1) (European Food Safety
Authority [EFSA]/European Centre for Disease Prevention and
Control [ECDC], 2017). Seventy-nine C. coli isolates (59.4%) and
three C. jejuni isolates (8.5%) showed resistance to ciprofloxacin
and erythromycin (treatment used against campylobacteriosis
before onset of resistance and the current treatment against
this bacteria). Campylobacter isolates resistant to erythromycin
(Table 1) were analyzed for the presence of RNA methylase gene
erm(B).
erm(B)-Carrying Campylobacter Isolates
from Turkeys
Among the 85 erythromycin-resistant isolates, two (2.4%) carried
the erm(B) gene: C. coli ZTA14/01086 and C. coli ZTA14/01426.
The C. coli ZTA14/01086 is resistant to ciprofloxacin/nalidixic
acid, tetracycline, erythromycin and streptomycin, whereas
C. coli ZTA14/01426 shares the same MDR pattern and
gentamicin resistance. The erythromycin-resistance MICs were
256 mg/L for C. coli ZTA14/01086 and >1024 mg/L for C. coli
ZTA14/01426. Whole genome sequencing revealed that the
erm(B) gene in C. coli ZTA14/01086 was located in a cluster along
with other resistance genes, including tet(O) and aad9 which
confer resistance to tetracycline and spectinomycin respectively
(Figure 1; GenBank accession number: MF134831). The genome
of C. coli ZTA14/01426 isolate contained the erm(B) gene in
a cluster with aminoglycoside resistance genes aph(2′′)-IIIa,
aph(3′)-IIIa, and aadE (Figure 1; GenBank accession number:
MF134832). Both genomic islands were compared with the
erm(B)-carrying genomic island from C. coli ZTA09/02204,
identified in Spain (GenBank accession number: KT953380)
(Figure 1 and Supplementary Table S2). Other than these
TABLE 1 | Drug resistance profiles found among 170 Campylobacter isolates
from turkeys.
Resistance C. coli C. jejuni
Profile1 No. of isolates (%) No. of isolates (%)
CTESG 9 (6.76) 0 (0)
CTES 46 (34.58) 1 (2.70)
CTSG 3 (2.25) 0 (0)
CTEG 1 (0.75) 0 (0)
CTE 23 (17.29) 2 (5.40)
CTS 20 (15.03) 1 (2.70)
TES 2 (1.5) 0 (0)
CT 29 (21.80) 28 (75.67)
TE 0 (0) 1 (2.70)
C 0 (0) 1 (2.70)
T 0 (0) 2 (5.40)
Susceptible 0 (0) 1 (2.70)
Total 133 (100.00) 37 (100.00)
1C, ciprofloxacin; T, tetracycline; E, erythromycin; S, streptomycin; G, gentamicin.
Combined resistance to nalidixic acid and ciprofloxacin were observed in both
Campylobacter species, therefore resistance is described to ciprofloxacin only.
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FIGURE 1 | Comparative genetic organization of erm(B)-carrying genomic islands from Campylobacter coli ZTA14/01086 (this study), C. coli ZTA 14/01426 (this
study) and previously identified C. coli ZTA09/02204 (17). Antimicrobial resistance genes are colored as follows: erm(B) gene (blue); aminoglycoside resistance genes
(yellow); the tetracycline resistance gene tet(O) (purple). Genes with other predicted functions or encoding hypothetical proteins are shown in white. Gray shading
indicates regions sharing 98% DNA identity.
resistance determinants, analysis of 23S rRNA and ribosomal
protein (L4 and L22) genes from genomes of the erm(B) positive
strains from turkeys, revealed the absence of ribosomal mutations
previously related with erythromycin resistance (Gibreel et al.,
2005).
erm(B) Allelic Variation among Bacterial
Genera, Hosts, and Countries
Comparison of sequence homology can provide information
about the horizontal transfer of resistance genes, including
erm(B), among bacterial species. The nucleotide sequences of 10
erm(B) genes present in Campylobacter were compared, two from
this study and eight of Chinese and Spanish origin. Using the first
erm(B) sequence described in Campylobacter as reference (C. coli
ZC113; GenBank accession number: KC575115), four alleles have
been identified in the erm(B) sequences from Campylobacter
(Supplementary Table S3). Allele 1 was the most common (7/10)
and was used as reference. Alleles 2 and 3 were present in only
one C. coli isolate each from Spain, with SNPs A299G (Asn-
100-Ser) and A353G (His-118-Arg), respectively. Allele 4 was
found in a C. jejuni isolate from China and is characterized by
the synonymous SNP C726T. Bacterial genera, hosts and origins
with erm(B) sequence identical to the four alleles observed in
Campylobacter were identified in the NCBI database, compiled
(Supplementary Table S3) and compared (Figure 2). The erm(B)
alleles detected in Campylobacter had been previously identified
mainly in Enterococcus and Staphylococcus isolated from humans
and pigs in Asia and Europe. Allele 1 of erm(B) is represented in
31 sequences from eight bacterial species, including Streptococcus
suis (11/31; 35.5%), Enterococcus faecium (7/31; 22.5%), and
C. coli (7/31; 22,5%). S. suis isolates were mainly isolated in
China (7/11; 63.6%) and all were from swine hosts. Sequences
of E. faecium were mainly from Japan (4/7; 57.1%) and all were
of human origin. The majority of erm(B) allele 1 sequences
from Campylobacter were of Chinese origin (6/7; 85.7%) and
sampled from humans, swine, and chickens. Allele 2 of erm(B)
was detected in 16 bacterial species mainly Clostridium difficile
(10/39; 25.6%) and E. faecium (7/39; 17.9%), from European and
United States people and pigs of Chinese origin, respectively.
Allele 2 of erm(B) is slightly less common in NCBI database than
allele 1, being the only one identified in six bacterial genomes,
mainly E. faecium (10/22; 45.4%) sampled from humans in the
United States, Australia, Japan and South Korea, whereas allele 4
of erm(B) was not identified in any other sequence available in
public databases.
DISCUSSION
Definitive characterization of erythromycin resistance in
bacterial pathogens is an important objective defined by the EFSA
and the European Centre for Disease Prevention and Control
(ECDC) (European Food Safety Authority [EFSA]/European
Centre for Disease Prevention and Control [ECDC], 2017).
To date, the erm(B) gene has been identified in Campylobacter
isolates from swine, chickens, ducks and humans from China
and in one broiler sample from Spain (Wang et al., 2014; Florez-
Cuadrado et al., 2016). Monitoring antimicrobial resistance in
Campylobacter isolated from turkeys has been mandatory since
2014 in European countries where the production of turkey
meat exceeds 10,000 tons per year (2016). The occurrence of
erythromycin resistant C. coli isolates from turkeys in Germany,
Romania and Spain had risen to 43.3% in 2014 (2016), compared
to previous surveys where lower frequencies were detected
for poultry (14.5%) and swine (20.7%) (European Food Safety
Authority [EFSA]/European Centre for Disease Prevention and
Control [ECDC], 2015, 2016b). Since Campylobacter infections
are related to consumption of food from animal origin, these
levels of resistance could potentially produce therapeutic failure
of antibiotic treatment for campylobacteriosis in humans.
Increased antimicrobial resistance among Campylobacter
populations is a consequence of the widespread acquisition
of antimicrobial resistance and clonal expansion of resistant
lineages (Wimalarathna et al., 2013). Campylobacter can
acquire DNA, including antimicrobial resistance genes, from
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FIGURE 2 | Host and geographical distribution of the erm(B) alleles identified in Campylobacter in this study among other bacterial genera. Allele 1 belongs to C. coli
ZTA14/01426 (MF134832), allele 2 belongs to C. coli ZTA09/02204 (KT953380), allele 3 belongs to C. coli ZTA14/01086 (MF134831) and allele 4 belongs to
C. jejuni C179b (KF864551). erm(B) homologs were identified in GenBank using BLAST with a coverage and similarity of 100%. Accession numbers of each
sequence is given in Supplementary Table S3. Sequences without host data and geographical location have not been included. Exact identity of erm(B) alleles
between species, host/environment and origin of isolation is represented by a connection (width proportional to relative prevalence).
relatively distantly related lineages through HGT, involving the
replacement of homologous sequences, or the acquisition of
mobile genetic elements (MGEs). There is evidence that plasmid
acquisition mediates Campylobacter resistance to tetracycline,
chloramphenicol and aminoglycosides (Courvalin et al., 1978;
Taylor et al., 1987; Wang and Taylor, 1990) but in some
cases, these resistances might be conferred by polymorphism of
chromosomal sequences. This is also the case in Campylobacter
for resistance to fluoroquinolones and macrolides, mediated
by mutations in gyrA or 23S rDNA sequences, respectively
(Engberg et al., 2001). Mutations that confer antimicrobial
resistance can occur independently in multiple lineages but can
also spread by natural transformation followed by homologous
recombination, leading to the dissemination of antimicrobial
resistance among bacteria that share an ecological niche (Meric
et al., 2015).
The increasing number of studies identifying erm(B) genes
in Campylobacter suggest that horizontal transfer is related to
macrolide resistance in Campylobacter (Qin et al., 2014; Wang
et al., 2014; Deng et al., 2015; Florez-Cuadrado et al., 2016;
European Food Safety Authority [EFSA]/European Centre for
Disease Prevention and Control [ECDC], 2017). High levels
of resistance among C. coli isolates have been previously
reported in isolates from livestock (Thakur and Gebreyes,
2005), potentially reflecting a selective advantage in these niches
and clonal expansion of resistance lineages. This study shows
the location of erm(B) gene in a genomic island along with
other antimicrobial resistance genes including tet(O), encoding
resistance to tetracycline and aph(3′)-IIIa, aacA-aphD, aad9 and
aadE, conferring resistance to different aminoglycosides (Qin
et al., 2014; Wang et al., 2014; Florez-Cuadrado et al., 2016),
a clustering that implies the possibility of co-selection as an
evolutionary mechanism (Chapman, 2003). In addition, linked
erm(B) and aph(2")-IIIa genes detected in the genome of C. coli
ZTA14/01426 isolate, could be transferred to virulent strains
limiting seriously the effectiveness of the two main choices
for treatment of severe campylobacteriosis, erythromycin and
gentamicin (Lehtopolku et al., 2009).
Although the presence of the erm(B) gene was evaluated on
a total of 85 Campylobacter isolates, the scope of the genomic
comparison was limited to only two C. coli because they were
positive for the erythromycin resistance gene. Despite the limited
number of genomes sequenced, the erm(B)-carrying genomic
islands identified in Campylobacter isolated from Spain show
genetic differences in comparison with ones from China. Thus,
the genomic islands identified in Spain do not correspond to
any of the six types of genomic islands identified in C. coli from
China (Qin et al., 2014; Wang et al., 2014; Florez-Cuadrado
et al., 2016). All of the erm(B)-carrying genomic islands posses
aminoglycoside resistance genes but the gentamicin resistance
gene aph(2")-IIIa is present only in Spanish isolates. Resistance
to gentamicin was represented in the Chinese erm(B)-carrying
sequences with the presence of the aacA-aphD gene and was
identified in C. coli isolates from humans, poultry, and swine
(Wang et al., 2014).
Identical antibiotic resistance gene nucleotide sequences
have been detected in both Gram-positive and Gram-negative
bacteria. This is consistent with HGT facilitating the spread of
resistance genes between distantly related species (Trieu-Cuot
et al., 1985; Courvalin, 1994). Gram-positive bacteria including
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Enterococcus, Streptococcus, and Staphylococcus are widely
known to harbor various resistance genes (Zilhao et al., 1988;
Pinto-Alphandary et al., 1990) and recently, tetracycline and
aminoglycoside resistance genes from Gram-positive bacteria
have been identified in Gram-negative bacteria including
Escherichia coli or Klebsiella pneumoniae (Arthur et al., 1987;
Brisson-Noel et al., 1988) and Campylobacter (Lambert et al.,
1985; Zilhao et al., 1988; Pinto-Alphandary et al., 1990). Four
erm(B) alleles were identified in Campylobacter in this study
(Supplementary Table S3) and comparison of these alleles with
those from other bacteria provides useful information about
possible routes of transmission (Figure 2). First, 100% nucleotide
identity with erm(B) genes from Enterococcus, Streptococcus,
Peptoclostridium, Anaerostipes, Arcanobacterium, Eggerthella,
Lactobacillus, Lactococcus, Macrococcus, and Selenomonas
suggests horizontal acquisition from Gram-positive bacteria, as
previously described (Qin et al., 2014; Wang et al., 2014; Florez-
Cuadrado et al., 2016). Second, the erm(B) alleles identified in
this study have been previously identified mainly in human
and porcine bacterial pathogens of Asian and European origin
(Figure 2). The pig and human pathogen S. suis is considered
a reservoir of antibiotic resistance genes (Palmieri et al., 2011)
and transferable genetic elements carrying the erm(B), tet(O)
and aminoglycoside resistance genes have previously been
reported in S. suis isolates (Palmieri et al., 2012). The use of
combined antibiotic therapies on swine farms potentially selects
for bacterial isolates carrying resistance to different antibiotics
(Zhu et al., 2013).
Allele 2 of the erm(B) gene has been identified in more
bacterial genera than the other alleles in this study (Figure 2).
All bacterial genera where erm(B) allele 2 has been identified
belong to the Firmicutes, with two exceptions that belong to
the Actinobacteria. These bacterial genera are present in the
gastrointestinal tract and species like Enterococcus, Streptococcus,
and Staphylococcus share the niche with Campylobacter (Zilhao
et al., 1988). The transfer of antibiotic resistance genes in the
human colon between bacteria of different genera has been
reported (Huddleston, 2014) and it is possible that the antibiotics
supplied in both animals and humans could facilitate the
selection of strains carrying these multiresistant genomic islands
and favor their dispersion. Identifying erm(B) genes and MDR
genomic islands in Campylobacter isolates from turkeys, adds
another component to the already extensive network of bacterial
genera and hosts involved in the possible dispersion of critical
antibiotic resistance genes and MGEs. This study highlights the
need to sequence a greater number of Campylobacter genomes
with the objective of evaluating the impact of genomic islands on
the dispersion of antimicrobial resistance genes in this genus.
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